These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance. Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552 [TBL] [Abstract][Full Text] [Related]
4. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi Y; Burn P Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736 [No Abstract] [Full Text] [Related]
5. Lipase Inhibitors for Obesity: A Review. Liu TT; Liu XT; Chen QX; Shi Y Biomed Pharmacother; 2020 Aug; 128():110314. PubMed ID: 32485574 [TBL] [Abstract][Full Text] [Related]
6. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Sasaoka T; Wada T; Tsuneki H Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Promises of Chlorogenic Acid with Special Emphasis on its Anti-Obesity Property. Kumar R; Sharma A; Iqbal MS; Srivastava JK Curr Mol Pharmacol; 2020; 13(1):7-16. PubMed ID: 31333144 [TBL] [Abstract][Full Text] [Related]
8. Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research. Ceccarelli SM; Chomienne O; Gubler M; Arduini A J Med Chem; 2011 May; 54(9):3109-52. PubMed ID: 21504156 [No Abstract] [Full Text] [Related]
9. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. Declercq PE; Falck JR; Kuwajima M; Tyminski H; Foster DW; McGarry JD J Biol Chem; 1987 Jul; 262(20):9812-21. PubMed ID: 3597441 [TBL] [Abstract][Full Text] [Related]
10. Kinetic investigation of carnitine palmitoyltransferases in homogenates of human skeletal muscle using L-amino-carnitine and malonyl-CoA. Hertel K; Gellerich FN; Hein W; Zierz S Adv Exp Med Biol; 1999; 466():87-93. PubMed ID: 10709631 [No Abstract] [Full Text] [Related]
11. Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity. Jheng HF; Huang SH; Kuo HM; Hughes MW; Tsai YS Ann N Y Acad Sci; 2015 Sep; 1350():82-94. PubMed ID: 26301786 [TBL] [Abstract][Full Text] [Related]